CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells (58). The gene discussed is IL1RAP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.